COGENT BIOSCIENCES INC's ticker is COGT and the CUSIP is 19240Q201. A total of 83 filers reported holding COGENT BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,621,114 | -73.4% | 1,089,345 | -67.6% | 0.23% | -72.5% |
| Q2 2023 | $39,857,525 | +24.5% | 3,366,345 | +13.5% | 0.85% | +19.2% |
| Q1 2023 | $32,006,863 | -6.7% | 2,966,345 | 0.0% | 0.71% | +0.6% |
| Q4 2022 | $34,290,948 | -22.5% | 2,966,345 | 0.0% | 0.71% | -19.4% |
| Q3 2022 | $44,258,000 | -16.5% | 2,966,345 | -49.5% | 0.88% | -19.4% |
| Q2 2022 | $53,009,000 | +342.1% | 5,876,805 | +267.1% | 1.09% | +307.8% |
| Q1 2022 | $11,991,000 | -12.7% | 1,601,000 | 0.0% | 0.27% | -6.9% |
| Q4 2021 | $13,737,000 | +2.0% | 1,601,000 | 0.0% | 0.29% | +9.5% |
| Q3 2021 | $13,464,000 | +3.7% | 1,601,000 | 0.0% | 0.26% | +13.9% |
| Q2 2021 | $12,984,000 | +47.9% | 1,601,000 | +60.1% | 0.23% | +24.9% |
| Q1 2021 | $8,780,000 | -21.8% | 1,000,000 | 0.0% | 0.18% | -16.7% |
| Q4 2020 | $11,230,000 | – | 1,000,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 1,558,975 | $17,507,000 | 6.26% |
| COMMODORE CAPITAL LP | 760,025 | $8,535,000 | 4.64% |
| Ally Bridge Group (NY) LLC | 1,622,591 | $18,222,000 | 3.12% |
| Ghost Tree Capital, LLC | 1,100,000 | $12,353,000 | 2.75% |
| Logos Global Management LP | 1,920,500 | $21,567,000 | 1.85% |
| Altium Capital Management LP | 432,563 | $4,858,000 | 1.81% |
| VR Adviser, LLC | 1,088,817 | $12,227,000 | 1.80% |
| Atlas Venture Associates IX, LLC | 916,196 | $10,289,000 | 1.63% |
| Atlas Venture Associates XI, LLC | 916,196 | $10,289,000 | 1.63% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 235,066 | $2,640,000 | 1.53% |